Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Pittenger

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Scientific Data|March 21, 2026
COVID Diaries, State Response to COVID Vaccination Program, December 2020 to September 2021Avalon S Moore, Bridget Vitu, Felicia Fraizer-Bisner, et al.
The Journal of Clinical Psychiatry|June 16, 2017
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive DisorderDaniel L C Costa, Juliana B Diniz, Guaraci Requena, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 17, 2023
Prefrontal allopregnanolone mediates the adverse effects of acute stress in a mouse model of tic pathophysiologyRoberto Cadeddu, Meghan Van Zandt, Luca Spiro Santovito, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndromeMeiyu Xu, Andrew Kobets, Jung-Chieh Du, et al.
Journal of Clinical Psychopharmacology|November 18, 2006
Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviorsDavid A Sasso, Paul S A Kalanithi, Kevin V Trueblood, et al.
Depression and Anxiety|August 31, 2021
Transcranial direct current stimulation targeting the medial prefrontal cortex modulates functional connectivity and enhances safety learning in obsessive-compulsive disorder: Results from two pilot studiesThomas G Adams, Josh M Cisler, Benjamin Kelmendi, et al.
Journal of Affective Disorders|July 17, 2025
Suicidal obsessions from suicidal ideation: A first-person suicide image pilot studyElizabeth F Mattera, Keila Sandoval, Carly Sipper, et al.
Neurobiology of Aging|July 16, 2019
Pharmacological antagonism of histamine H2R ameliorated L-DOPA-induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PDMohamed Rafiuddin Ahmed, Mithya Jayakumar, Mohamed Sohail Ahmed, et al.
Biological Psychiatry|July 13, 2012
Effects of ketamine in treatment-refractory obsessive-compulsive disorderMichael H Bloch, Suzanne Wasylink, Angeli Landeros-Weisenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse modelYongfang Zhang, Pradeep Kurup, Jian Xu, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Scientific Data|March 21, 2026
COVID Diaries, State Response to COVID Vaccination Program, December 2020 to September 2021Avalon S Moore, Bridget Vitu, Felicia Fraizer-Bisner, et al.
The Journal of Clinical Psychiatry|June 16, 2017
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive DisorderDaniel L C Costa, Juliana B Diniz, Guaraci Requena, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 17, 2023
Prefrontal allopregnanolone mediates the adverse effects of acute stress in a mouse model of tic pathophysiologyRoberto Cadeddu, Meghan Van Zandt, Luca Spiro Santovito, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 2015
Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndromeMeiyu Xu, Andrew Kobets, Jung-Chieh Du, et al.
Journal of Clinical Psychopharmacology|November 18, 2006
Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviorsDavid A Sasso, Paul S A Kalanithi, Kevin V Trueblood, et al.
Depression and Anxiety|August 31, 2021
Transcranial direct current stimulation targeting the medial prefrontal cortex modulates functional connectivity and enhances safety learning in obsessive-compulsive disorder: Results from two pilot studiesThomas G Adams, Josh M Cisler, Benjamin Kelmendi, et al.
Journal of Affective Disorders|July 17, 2025
Suicidal obsessions from suicidal ideation: A first-person suicide image pilot studyElizabeth F Mattera, Keila Sandoval, Carly Sipper, et al.
Neurobiology of Aging|July 16, 2019
Pharmacological antagonism of histamine H2R ameliorated L-DOPA-induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PDMohamed Rafiuddin Ahmed, Mithya Jayakumar, Mohamed Sohail Ahmed, et al.
Biological Psychiatry|July 13, 2012
Effects of ketamine in treatment-refractory obsessive-compulsive disorderMichael H Bloch, Suzanne Wasylink, Angeli Landeros-Weisenberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse modelYongfang Zhang, Pradeep Kurup, Jian Xu, et al.
Pageof 19